Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.

Insulin-like growth factor I (IGF-I) and its type I receptor (IGF-IR) play significant roles in tumorigenesis and in immune response. Here, we wanted to know whether an RNA interference approach targeted to IGF-IR could be used for specific antitumor immunostimulation in a breast cancer model. For t...

Full description

Bibliographic Details
Main Authors: Tiphanie Durfort, Mercedes Tkach, Mariya I Meschaninova, Martín A Rivas, Patricia V Elizalde, Alya G Venyaminova, Roxana Schillaci, Jean-Christophe François
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22235273/?tool=EBI
_version_ 1798032677702467584
author Tiphanie Durfort
Mercedes Tkach
Mariya I Meschaninova
Martín A Rivas
Patricia V Elizalde
Alya G Venyaminova
Roxana Schillaci
Jean-Christophe François
author_facet Tiphanie Durfort
Mercedes Tkach
Mariya I Meschaninova
Martín A Rivas
Patricia V Elizalde
Alya G Venyaminova
Roxana Schillaci
Jean-Christophe François
author_sort Tiphanie Durfort
collection DOAJ
description Insulin-like growth factor I (IGF-I) and its type I receptor (IGF-IR) play significant roles in tumorigenesis and in immune response. Here, we wanted to know whether an RNA interference approach targeted to IGF-IR could be used for specific antitumor immunostimulation in a breast cancer model. For that, we evaluated short interfering RNA (siRNAs) for inhibition of in vivo tumor growth and immunological stimulation in immunocompetent mice. We designed 2'-O-methyl-modified siRNAs to inhibit expression of IGF-IR in two murine breast cancer cell lines (EMT6, C4HD). Cell transfection of IGF-IR siRNAs decreased proliferation, diminished phosphorylation of downstream signaling pathway proteins, AKT and ERK, and caused a G0/G1 cell cycle block. The IGF-IR silencing also induced secretion of two proinflammatory cytokines, TNF- α and IFN-γ. When we transfected C4HD cells with siRNAs targeting IGF-IR, mammary tumor growth was strongly delayed in syngenic mice. Histology of developing tumors in mice grafted with IGF-IR siRNA treated C4HD cells revealed a low mitotic index, and infiltration of lymphocytes and polymorphonuclear neutrophils, suggesting activation of an antitumor immune response. When we used C4HD cells treated with siRNA as an immunogen, we observed an increase in delayed-type hypersensitivity and the presence of cytotoxic splenocytes against wild-type C4HD cells, indicative of evolving immune response. Our findings show that silencing IGF-IR using synthetic siRNA bearing 2'-O-methyl nucleotides may offer a new clinical approach for treatment of mammary tumors expressing IGF-IR. Interestingly, our work also suggests that crosstalk between IGF-I axis and antitumor immune response can mobilize proinflammatory cytokines.
first_indexed 2024-04-11T20:16:38Z
format Article
id doaj.art-1281f05586784fbebb30d23de245a527
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T20:16:38Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1281f05586784fbebb30d23de245a5272022-12-22T04:04:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0171e2921310.1371/journal.pone.0029213Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.Tiphanie DurfortMercedes TkachMariya I MeschaninovaMartín A RivasPatricia V ElizaldeAlya G VenyaminovaRoxana SchillaciJean-Christophe FrançoisInsulin-like growth factor I (IGF-I) and its type I receptor (IGF-IR) play significant roles in tumorigenesis and in immune response. Here, we wanted to know whether an RNA interference approach targeted to IGF-IR could be used for specific antitumor immunostimulation in a breast cancer model. For that, we evaluated short interfering RNA (siRNAs) for inhibition of in vivo tumor growth and immunological stimulation in immunocompetent mice. We designed 2'-O-methyl-modified siRNAs to inhibit expression of IGF-IR in two murine breast cancer cell lines (EMT6, C4HD). Cell transfection of IGF-IR siRNAs decreased proliferation, diminished phosphorylation of downstream signaling pathway proteins, AKT and ERK, and caused a G0/G1 cell cycle block. The IGF-IR silencing also induced secretion of two proinflammatory cytokines, TNF- α and IFN-γ. When we transfected C4HD cells with siRNAs targeting IGF-IR, mammary tumor growth was strongly delayed in syngenic mice. Histology of developing tumors in mice grafted with IGF-IR siRNA treated C4HD cells revealed a low mitotic index, and infiltration of lymphocytes and polymorphonuclear neutrophils, suggesting activation of an antitumor immune response. When we used C4HD cells treated with siRNA as an immunogen, we observed an increase in delayed-type hypersensitivity and the presence of cytotoxic splenocytes against wild-type C4HD cells, indicative of evolving immune response. Our findings show that silencing IGF-IR using synthetic siRNA bearing 2'-O-methyl nucleotides may offer a new clinical approach for treatment of mammary tumors expressing IGF-IR. Interestingly, our work also suggests that crosstalk between IGF-I axis and antitumor immune response can mobilize proinflammatory cytokines.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22235273/?tool=EBI
spellingShingle Tiphanie Durfort
Mercedes Tkach
Mariya I Meschaninova
Martín A Rivas
Patricia V Elizalde
Alya G Venyaminova
Roxana Schillaci
Jean-Christophe François
Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
PLoS ONE
title Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
title_full Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
title_fullStr Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
title_full_unstemmed Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
title_short Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
title_sort small interfering rna targeted to igf ir delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22235273/?tool=EBI
work_keys_str_mv AT tiphaniedurfort smallinterferingrnatargetedtoigfirdelaystumorgrowthandinducesproinflammatorycytokinesinamousebreastcancermodel
AT mercedestkach smallinterferingrnatargetedtoigfirdelaystumorgrowthandinducesproinflammatorycytokinesinamousebreastcancermodel
AT mariyaimeschaninova smallinterferingrnatargetedtoigfirdelaystumorgrowthandinducesproinflammatorycytokinesinamousebreastcancermodel
AT martinarivas smallinterferingrnatargetedtoigfirdelaystumorgrowthandinducesproinflammatorycytokinesinamousebreastcancermodel
AT patriciavelizalde smallinterferingrnatargetedtoigfirdelaystumorgrowthandinducesproinflammatorycytokinesinamousebreastcancermodel
AT alyagvenyaminova smallinterferingrnatargetedtoigfirdelaystumorgrowthandinducesproinflammatorycytokinesinamousebreastcancermodel
AT roxanaschillaci smallinterferingrnatargetedtoigfirdelaystumorgrowthandinducesproinflammatorycytokinesinamousebreastcancermodel
AT jeanchristophefrancois smallinterferingrnatargetedtoigfirdelaystumorgrowthandinducesproinflammatorycytokinesinamousebreastcancermodel